VKA vs. NOAC advantages in application-related patient safety

Autor:	Krek, C, Grave, B, Heeke, A
Jazyk:	angličtina
Rok vydání:	2015
Předmět:	ddc: 610 610 Medical sciences Medicine
Zdroj:	22. Jahrestagung der Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie; 20151203-20151204; Dresden; DOC15gaa19 /20151209/
DOI:	10.3205/15gaa19
Popis:	Background: An optimal adjustment In Patients with atrial fibrillation is crucial to decrease their mortality. So far there have been only few substances for their treatment, VKA as standard-mediaction and heparines with measurable, but subordinated amount. Marcumar is characterized by its small therapeutic[for full text, please go to the a.m. URL] 22. Jahrestagung der Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef455d4438c10da7049608a9a11a995b Zobrazit plný text záznamu